Jeffrey Michael Shea, M.D.

NPI 1972658425ActiveIndividual· Internal Medicine, Pulmonary Disease· Longview, TX

Internal Medicine, Pulmonary Disease (M.D.) in Longview, Texas, trained at University of Texas Medical School at Houston (class of 1988). Their prescriptions cost Medicare Part D more than their services did: $1,197,965 for 2,213 claims, against $364,108 paid for services in 2024. Glaxosmithkline, LLC. was the largest of 20 companies reporting payments in 2025, $1,466 in all, mostly food and beverage.

Overview

NPI	1972658425
Status	Active
Entity type	Individual
Credential	M.D.
Sole proprietor	No
NPI issued	Jan 24, 2007
Last updated in NPPES	Jan 24, 2023
Certified by provider	Jan 24, 2023

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Pulmonary Disease Primary	207RP1001X	H6598	TX
Internal Medicine, Sleep Medicine	207RS0012X	H6598	TX

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Pulmonary Disease (TX)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	1,069
Services billed	5,595 across 76 procedure codes
Paid by Medicare	$364,108

Part D prescriptions in 2024

Prescriptions (claims)	2,213 · 2,829 30-day fills
Patients	445
Total drug cost	$1,197,965
Generic share	38% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of Texas Medical School at Houston
Graduation year	1988
Medicare specialty	Pulmonary Disease
Secondary specialties	Internal Medicine